Abstract
Amyotrophic lateral sclerosis (ALS), commonly termed as motor neuron disease (MND) in UK, is a chronically lethal disorder among the neurodegenerative diseases, meanwhile. ALS is basically irreversible and progressive deterioration of upper and lower motor neurons in the motor cortex, brain stem and medulla spinalis. Riluzole, used for the treatment of ALS, was demonstrated to slightly delay the initiation of respiratory dysfunction and extend the median survival of patients by a few months. In this study, the key biochemical defects were discussed, such as: mutant Cu/Zn superoxide dismutase, mitochondrial protectants, and anti-excitotoxic/ anti-oxidative / antiinflammatory/ anti-apoptotic agents, so the related drug candidates that have been studied in ALS models would possibly be further used in ALS patients.
Citations
Apr 28, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·David B BanksRonald E Cannon
Feb 8, 2020·Indian Journal of Pharmacology·Gitika BatraBikash Medhi
Oct 8, 2016·Journal of Cellular Biochemistry·Thangavelu Soundara RajanOriana Trubiani
Mar 7, 2017·F1000Research·Mark KindyDorothy Ko
May 22, 2019·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·D Michal FreedmanRuth M Pfeiffer
Apr 16, 2018·Molecular Neurobiology·Silvia RaveraGiambattista Bonanno
Sep 22, 2019·International Journal of Molecular Sciences·Tiziana BonifacinoGiambattista Bonanno
Apr 25, 2019·Proteins·Bar DaganNiv Papo
Jul 10, 2019·Journal of Neurochemistry·Silvia RaveraGiambattista Bonanno
May 16, 2019·Antioxidants & Redox Signaling·Elsa Cortés-MonteroJavier Garzón
Oct 7, 2020·International Journal of Molecular Sciences·María Rodríguez-MuñozPilar Sánchez-Blázquez
Jan 7, 2021·Molecular Neurobiology·Elsa Cortés-MonteroJavier Garzón-Niño
Oct 31, 2020·Oxidative Medicine and Cellular Longevity·Monika PichlaIzabela Sadowska-Bartosz
Dec 5, 2020·Oxidative Medicine and Cellular Longevity·Teresa Cunha-OliveiraFilomena S G Silva
Feb 27, 2021·Clinical and Translational Medicine·Barış GençP Hande Özdinler
Apr 4, 2021·International Journal of Molecular Sciences·Serena SilvestroEmanuela Mazzon
Feb 8, 2020·Current Neuropharmacology·Shareen Singh, Thakur Gurjeet Singh
Jul 3, 2021·International Journal of Molecular Sciences·Christine Péladeau, Jagdeep K Sandhu
May 2, 2021·British Journal of Pharmacology·Marco MilaneseGiambattista Bonanno
Aug 11, 2021·Translational Neurodegeneration·Xiaojiao XuSheng Chen